Prospective of Pancreatic Cancer Diagnosis Using Cardiac Sensing
Authors:
- Mansunderbir SinghMSMansunderbir Singh
- Priyanka AnvekarPAPriyanka Anvekar
- Bhavana BaraskarBBBhavana Baraskar
- Namratha PallipamuNPNamratha Pallipamu
- Srikanth GadamSGSrikanth Gadam
- Akhila Sai Sree CherukuriACAkhila Sai Sree Cherukuri
- Devanshi N. DamaniDDDevanshi N. Damani
- Kanchan KulkarniKKKanchan Kulkarni
- Shivaram P. ArunachalamShivaram P. Arunachalam
Open Access
- 25 July 2023
- journal article
- review article
- Published by MDPI AG in Journal of Imaging
- Vol. 9 (8) , 149
Abstract
Pancreatic carcinoma (Ca Pancreas) is the third leading cause of cancer-related deaths in the world. The malignancies of the pancreas can be diagnosed with the help of various imaging modalities. An endoscopic ultrasound with a tissue biopsy is so far considered to be the gold standard in terms of the detection of Ca Pancreas, especially for lesions <2 mm. However, other methods, like computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI), are also conventionally used. Moreover, newer techniques, like proteomics, radiomics, metabolomics, and artificial intelligence (AI), are slowly being introduced for diagnosing pancreatic cancer. Regardless, it is still a challenge to diagnose pancreatic carcinoma non-invasively at an early stage due to its delayed presentation. Similarly, this also makes it difficult to demonstrate an association between Ca Pancreas and other vital organs of the body, such as the heart. A number of studies have proven a correlation between the heart and pancreatic cancer. The tumor of the pancreas affects the heart at the physiological, as well as the molecular, level. An overexpression of the SMAD4 gene; a disruption in biomolecules, such as IGF, MAPK, and ApoE; and increased CA19-9 markers are a few of the many factors that are noted to affect cardiovascular systems with pancreatic malignancies. A comprehensive review of this correlation will aid researchers in conducting studies to help establish a definite relation between the two organs and discover ways to use it for the early detection of Ca Pancreas.Keywords
Funding Information
- Advanced Analytics and Practice Innovation unit for Artificial Intelligence and Informatics research within the Department of Medicine, Mayo Clinic, Rochester, MN USA
- GIH Division for the GIH Artificial Intelligence Laboratory (GAIL) and Microwave Engineering and Imaging Laboratory (MEIL), Department of Medicine, Mayo Clinic, Rochester, MN USA
This publication has 103 references indexed in Scilit:
- IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancerBMC Cancer, 2013
- Differentiation of Pancreatic Cancer and Chronic Pancreatitis Using Computer-Aided Diagnosis of Endoscopic Ultrasound (EUS) Images: A Diagnostic TestPLOS ONE, 2013
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive PatientsPLOS ONE, 2012
- Sensing Movement: Microsensors for Body Motion MeasurementSensors, 2011
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabineBritish Journal of Cancer, 2010
- Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking TalePhysiological Reviews, 2010
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Pancreatic cancer: Pathogenesis, prevention and treatmentToxicology and Applied Pharmacology, 2007
- TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENTAnnual Review of Pathology: Mechanisms of Disease, 2006